{"name":"Amgen Ventures","permalink":"amgen-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/amgen-ventures","homepage_url":null,"blog_url":null,"blog_feed_url":null,"twitter_username":null,"phone_number":null,"description":null,"email_address":null,"number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":null,"created_at":"Tue Jun 16 16:42:07 UTC 2009","updated_at":"Sat Jul 11 04:06:15 UTC 2009","overview":"<p>As a company formed with venture capital funding more than 25 years ago, they understand the challenges faced by early-stage biotechnology companies. In 2004, they announced the formation of Amgen Ventures, their corporate venture capital fund. With an initial investment of $100 million, the fund is designed to provide emerging biotechnology companies with resources to develop pioneering discoveries focused on human therapeutics. Amgen Ventures reflects Amgen&#8217;s commitment to helping patients by transforming cutting-edge scientific discoveries into novel treatments for serious illness.</p>","image":null,"offices":[],"relationships":[],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.biospace.com/news_story.aspx?StoryID=143295&full=1","source_description":"\r\n","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":3,"company":{"name":"Miragen Therapeutics","permalink":"miragen-therapeutics","image":{"available_sizes":[[[150,79],"assets/images/resized/0004/7290/47290v1-max-150x150.jpg"],[[243,129],"assets/images/resized/0004/7290/47290v1-max-250x250.jpg"],[[243,129],"assets/images/resized/0004/7290/47290v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2008/08/04/interkrin-raises-185-for-continued-work-on-diabetes-drug/","source_description":"InteKrin raises $18.5M for continued work on diabetes drug","raised_amount":18500000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":4,"company":{"name":"InteKrin","permalink":"interkrin","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0799/50799v1-max-150x150.png"],[[184,52],"assets/images/resized/0005/0799/50799v1-max-250x250.png"],[[184,52],"assets/images/resized/0005/0799/50799v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Capital Report Index","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":5,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/epizyme-pulls-32m-vc-capital-new-investors/2009-10-07?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0#ixzz0TIDqj9B1","source_description":"Epizyme pulls in $32M in VC capital, new investors","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":7,"company":{"name":"Epizyme","permalink":"epizyme","image":{"available_sizes":[[[150,74],"assets/images/resized/0006/1969/61969v1-max-150x150.jpg"],[[250,124],"assets/images/resized/0006/1969/61969v1-max-250x250.jpg"],[[450,224],"assets/images/resized/0006/1969/61969v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2009/11/09/trinity-biosystems-raises-7-5m-bridge-to-treat-endocrine-disorders/","source_description":"Trinity Biosystems raises $7.5M bridge to treat endocrine disorders","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":9,"company":{"name":"Trinity Biosystems","permalink":"trinity-biosystems","image":{"available_sizes":[[[150,51],"assets/images/resized/0006/5604/65604v1-max-150x150.jpg"],[[223,77],"assets/images/resized/0006/5604/65604v1-max-250x250.jpg"],[[223,77],"assets/images/resized/0006/5604/65604v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.allbusiness.com/company-activities-management/board-management-changes/5299825-1.html","source_description":"Allozyne, Inc., Closes $30 Million Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":26,"company":{"name":"Allozyne","permalink":"allozyne","image":{"available_sizes":[[[143,150],"assets/images/resized/0008/0052/80052v1-max-150x150.jpg"],[[239,250],"assets/images/resized/0008/0052/80052v1-max-250x250.jpg"],[[244,255],"assets/images/resized/0008/0052/80052v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://calistogapharma.com/pdf/CalistogaFinancing_March2007.pdf","source_description":"Calistoga Pharmaceuticals, a newly formed drug development company, announces its formation and completion of a $21 million Series A financing","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":5,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://salesandmarketingnetwork.com/news_release.php?ID=2019125","source_description":"Argolyn Bioscience Raises $15.8 Million Round of Financing","raised_amount":15800000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":25,"company":{"name":"Argolyn Bioscience","permalink":"argolyn-bioscience","image":{"available_sizes":[[[150,23],"assets/images/resized/0008/0194/80194v1-max-150x150.jpg"],[[250,38],"assets/images/resized/0008/0194/80194v1-max-250x250.jpg"],[[297,46],"assets/images/resized/0008/0194/80194v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.vlstcorp.com/files/pr/pr061606.pdf","source_description":"VLST Corporation Raises $55 Million","raised_amount":55000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":16,"company":{"name":"VLST Corporation","permalink":"vlst-corporation","image":{"available_sizes":[[[150,76],"assets/images/resized/0008/4234/84234v1-max-150x150.jpg"],[[189,96],"assets/images/resized/0008/4234/84234v1-max-250x250.jpg"],[[189,96],"assets/images/resized/0008/4234/84234v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.freshnews.com/news/62624/mountain-view-avidia-raises-438-million-advance-new-class-pharmaceuticals","source_description":"AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS","raised_amount":43800000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":9,"company":{"name":"Avidia","permalink":"avidia","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.vironinc.com/press-releases/viron-therapeutics-raises-us-20-million-3.htm","source_description":"Viron Therapeutics raises US $20 million","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":16,"company":{"name":"Viron Therapeutics","permalink":"viron-therapeutics","image":{"available_sizes":[[[150,72],"assets/images/resized/0008/4429/84429v1-max-150x150.jpg"],[[208,100],"assets/images/resized/0008/4429/84429v1-max-250x250.jpg"],[[208,100],"assets/images/resized/0008/4429/84429v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Cap Funding Report","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":7,"funded_day":18,"company":{"name":"Trinity Biosystems","permalink":"trinity-biosystems","image":{"available_sizes":[[[150,51],"assets/images/resized/0006/5604/65604v1-max-150x150.jpg"],[[223,77],"assets/images/resized/0006/5604/65604v1-max-250x250.jpg"],[[223,77],"assets/images/resized/0006/5604/65604v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.thefreelibrary.com/AVIDIA+ADVANCING+LEAD+PRODUCT+THROUGH+$28.5M+SERIES+B+ROUND.-a0132169338","source_description":"AVIDIA ADVANCING LEAD PRODUCT THROUGH $28.5M SERIES B ROUND.","raised_amount":28500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":5,"funded_day":6,"company":{"name":"Avidia","permalink":"avidia","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ptct.client.shareholder.com/releasedetail.cfm?ReleaseID=197021","source_description":"PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING","raised_amount":26600000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":10,"company":{"name":"PTC Therapeutics","permalink":"ptc-therapeutics","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/seattle/2010/03/19/theraclone-raises-1-5m/","source_description":"Theraclone Raises $1.5M","raised_amount":1500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Theraclone Sciences","permalink":"theraclone-sciences","image":{"available_sizes":[[[150,32],"assets/images/resized/0009/4651/94651v1-max-150x150.jpg"],[[250,54],"assets/images/resized/0009/4651/94651v1-max-250x250.jpg"],[[305,67],"assets/images/resized/0009/4651/94651v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetralogic-nabs-32m-round-lead-cancer-therapy/2010-08-10?utm_medium=rss&utm_source=rss","source_description":"TetraLogic nabs $32M round for lead cancer therapy  Read more: TetraLogic nabs $32M round for lead cancer therapy","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.calistogapharma.com/pdf/FINAL%20CALPharma%20Series%20C%20release%206.30.10.pdf","source_description":"Calistoga Pharmaceuticals Raises $40 Million in Series C Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":30,"company":{"name":"Calistoga Pharmaceuticals","permalink":"calistoga-pharmaceuticals","image":{"available_sizes":[[[150,85],"assets/images/resized/0005/2159/52159v2-max-150x150.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-250x250.jpg"],[[217,124],"assets/images/resized/0005/2159/52159v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.goodwinprocter.com/News-and-Events/Press-Releases/2005/Allozyne-Inc-Raises-35-Million-in-Series-A-Funding.aspx","source_description":"Allozyne Inc. Raises $3.5 Million in Series A Funding","raised_amount":3500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":6,"company":{"name":"Allozyne","permalink":"allozyne","image":{"available_sizes":[[[143,150],"assets/images/resized/0008/0052/80052v1-max-150x150.jpg"],[[239,250],"assets/images/resized/0008/0052/80052v1-max-250x250.jpg"],[[244,255],"assets/images/resized/0008/0052/80052v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2010/09/decimmune-therapeutics-receives-1m-in.html","source_description":"DecImmune Therapeutics Receives $1M in Equity Financing; $2.2M Phase II SBIR Funding","raised_amount":3200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":27,"company":{"name":"DecImmune Therapeutics","permalink":"decimmune-therapeutics","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/11/sutro-biopharma-secures-365m-in-series.html","source_description":"Sutro Biopharma Secures $36.5M in Series C Financing","raised_amount":36500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":17,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/acylin-therapeutics-inc-series-a-44m/","source_description":"Acylin Therapeutics, Inc.: Series A $4.4M","raised_amount":4400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":11,"company":{"name":"Acylin Therapeutics","permalink":"acylin-therapeutics","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/oncofactor-inc-series-a-21m/","source_description":"Oncofactor, Inc.: Series A $2.1M","raised_amount":2100000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":2,"company":{"name":"Oncofactor Corporation","permalink":"oncofactor-corporation","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.ardelyx.com/news/ardelyx-inc-closes-30m-series-b-financing/","source_description":"Ardelyx, Inc. Closes $30M Series B Financing ","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":31,"company":{"name":"Ardelyx","permalink":"ardelyx","image":{"available_sizes":[[[150,35],"assets/images/resized/0015/2130/152130v1-max-150x150.png"],[[250,58],"assets/images/resized/0015/2130/152130v1-max-250x250.png"],[[270,63],"assets/images/resized/0015/2130/152130v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/04/miragen-therapeutics-completes-20m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"MiRagen Therapeutics Completes $20M Series B Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":24,"company":{"name":"Miragen Therapeutics","permalink":"miragen-therapeutics","image":{"available_sizes":[[[150,79],"assets/images/resized/0004/7290/47290v1-max-150x150.jpg"],[[243,129],"assets/images/resized/0004/7290/47290v1-max-250x250.jpg"],[[243,129],"assets/images/resized/0004/7290/47290v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://finance.yahoo.com/news/sutro-closes-16-5-million-113000166.html","source_description":"Sutro Closes $16.5 Million Second Tranche of Series C Financing","raised_amount":16500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":8,"company":{"name":"Sutro Biopharma","permalink":"sutro-biopharma","image":{"available_sizes":[[[139,102],"assets/images/resized/0011/0831/110831v1-max-150x150.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-250x250.png"],[[139,102],"assets/images/resized/0011/0831/110831v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}